Document 0818 DOCN M9460818 TI Epstein-Barr virus-related lymphomagenesis in a child with Wiskott-Aldrich syndrome. DT 9404 AU Gulley ML; Chen CL; Raab-Traub N; Department of Pathology, University of North Carolina, Chapel; Hill. SO Hematol Oncol. 1993 May-Jun;11(3):139-45. Unique Identifier : AIDSLINE MED/94156331 AB Epstein-Barr virus (EBV) DNA was detected in immunoblastic lymphoma arising in a child with the primary immunodeficiency, Wiskott-Aldrich syndrome. Southern blot analysis of the structure of the EBV genome revealed that the lymphoma was monoclonal and contained episomal EBV DNA. The EBV latent genes, latent membrane protein 1 (LMP1) and the EBV nuclear antigen 2 (EBNA2), were detected by immunohistochemistry in the Wiskott-Aldrich lymphoma but not in an EBV-positive Burkitt's lymphoma, implying that host immune factors could influence EBV gene expression. Hybridization in situ demonstrated expression of EBV-encoded RNA (EBER), the cellular c-fgr protooncogene, and CD23 B-cell activation transcripts in the Wiskott-Aldrich lymphoma whereas EBER and c-fgr but not CD23 were expressed in the Burkitt's lymphoma. These data suggest that in primary immunodeficiency-related lymphoma, LMP1 and EBNA2 are expressed and that this expression correlates with expression of CD23. This supports previous in vitro studies showing that CD23 is specifically induced by LMP1 or EBNA2 genes. In contrast, expression of c-fgr may be independent of expression of these EBV latent genes. DE Adolescence Antigens, Viral/ANALYSIS Colonic Neoplasms/*ETIOLOGY DNA-Binding Proteins/ANALYSIS DNA, Viral/ANALYSIS Herpesvirus 4, Human/GENETICS/*PATHOGENICITY Human Lymphoma/*ETIOLOGY Male Proto-Oncogene Proteins/GENETICS Proto-Oncogenes Receptors, IgE/ANALYSIS RNA, Viral/ANALYSIS Support, Non-U.S. Gov't Support, U.S. Gov't, Non-P.H.S. Support, U.S. Gov't, P.H.S. Wiskott-Aldrich Syndrome/*COMPLICATIONS JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).